Sorrento Therapeutics, Inc. - Nov 10, 2022 Form 3 Insider Report for Vickers Vantage Corp. I (SCLX)

Role
10%+ Owner
Signature
/s/ Jaisim Shah, Attorney-in-Fact
Stock symbol
SCLX
Transactions as of
Nov 10, 2022
Transactions value $
$0
Form type
3
Date filed
11/15/2022, 05:27 PM
Previous filing
Jul 23, 2021
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SCLX Common Stock 136M Nov 10, 2022 Direct
holding SCLX Series A Preferred Stock 29.1M Nov 10, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney